SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-006913
Filing Date
2019-04-23
Accepted
2019-04-23 06:18:36
Documents
5
Period of Report
2019-04-23

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k042219b_biondvaxpharma.htm 6-K 13098
2 NOTICE AND PROXY STATEMENT AND FORM OF VOTING INSTRUCTION CARD f6k042219bex99-1_biondvax.htm EX-99.1 683849
3 GRAPHIC img_001.jpg GRAPHIC 14796
4 GRAPHIC slide1.jpg GRAPHIC 383012
5 GRAPHIC slide2.jpg GRAPHIC 199065
  Complete submission text file 0001213900-19-006913.txt   1477164
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 19760596
SIC: 2836 Biological Products, (No Diagnostic Substances)